Related references
Note: Only part of the references are listed.Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Rohit Aggarwal et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis
Koji Nagai et al.
Modern Rheumatology (2014)
Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
Modern Rheumatology (2014)
Diffuse alveolar damage in patients with dermatomyositis: a six-case series
Yuko Matsuki et al.
Modern Rheumatology (2014)
Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease
Lorenzo Cavagna et al.
JOURNAL OF RHEUMATOLOGY (2013)
Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
Yasuhito Hamaguchi et al.
PLOS ONE (2013)
Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis
Kazuyoshi Ishigaki et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity
Baptiste Hervier et al.
AUTOIMMUNITY REVIEWS (2012)
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome
I. Marie et al.
RESPIRATORY MEDICINE (2012)
Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM
Takahisa Gono et al.
RHEUMATOLOGY (2012)
Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab
Jin-Kyoung Park et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment
Tsuneyo Mimori et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Short-Term and Long-Term Outcomes of Interstitial Lung Disease in Polymyositis and Dermatomyositis A Series of 107 Patients
I. Marie et al.
ARTHRITIS AND RHEUMATISM (2011)
Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia
Takuya Kotani et al.
CLINICAL RHEUMATOLOGY (2011)
Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan
Yoshioki Yamasaki et al.
JOURNAL OF RHEUMATOLOGY (2011)
Therapy of polymyositis and dermatomyositis
Isabelle Marie
PRESSE MEDICALE (2011)
Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies What Progress Has Been Made in the Past 35 Years?
Geoffrey R. Connors et al.
CHEST (2010)
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study
Henrik Ekberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
Ran Nakashima et al.
RHEUMATOLOGY (2010)
Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2010)
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2010)
Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
Pamela A. Morganroth et al.
ARTHRITIS CARE & RESEARCH (2010)
Pneumomediastinum in Interstitial Lung Disease Associated With Dermatomyositis and Polymyositis
Benoit Le Goff et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
RNA Helicase Encoded by Melanoma Differentiation-Associated Gene 5 Is a Major Autoantigen in Patients With Clinically Amyopathic Dermatomyositis Association With Rapidly Progressive Interstitial Lung Disease
Shinji Sato et al.
ARTHRITIS AND RHEUMATISM (2009)
Interstitial lung disease in polymyositis and dermatomyositis
I-Jung Chen et al.
CLINICAL RHEUMATOLOGY (2009)
Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis
Yuzo Suzuki et al.
LUNG (2009)
Rituximab treatment of the anti-synthetase syndrome-a retrospective case series
Marthe Sem et al.
RHEUMATOLOGY (2009)
Interstitial lung disease in polymyositis and dermatomyositis
I-Jung Chen et al.
CLINICAL RHEUMATOLOGY (2009)
Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: A case report
Antonio Furlan et al.
JOINT BONE SPINE (2008)
FKBP Family Proteins: Immunophilins with Versatile Biological Functions
Cong Bao Kang et al.
NEUROSIGNALS (2008)
Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study
Shuang Ye et al.
CLINICAL RHEUMATOLOGY (2007)
Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis
Jin Won Huh et al.
RESPIRATORY MEDICINE (2007)
Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia
Z. Betteridge et al.
RHEUMATOLOGY (2007)
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
Y. Yamasaki et al.
RHEUMATOLOGY (2007)
Interstitial lung disease in polymyositis and dermatomyositis
M Fathi et al.
CURRENT OPINION IN RHEUMATOLOGY (2005)
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
AC Webster et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis
EH Kang et al.
RHEUMATOLOGY (2005)
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus
MR Wilkes et al.
ARTHRITIS AND RHEUMATISM (2005)
Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants
K Takada et al.
AUTOIMMUNITY (2005)
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis
S Sato et al.
ARTHRITIS AND RHEUMATISM (2005)
New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis
O Heisel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
V Cottin et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Interstitial lung disease in polymyositis and dermatomyositis
I Marie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Idiopathic inflammatory myopathy with diffuse alveolar damage
CS Lee et al.
CLINICAL RHEUMATOLOGY (2002)
Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis
K Kurasawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study
R Margreiter
LANCET (2002)
Polymyositis-dermatomyositis-associated interstitial lung disease
WW Douglas et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
FK506, an immunosuppressant targeting calcineurin function
FJ Dumont
CURRENT MEDICINAL CHEMISTRY (2000)
Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis
F Tanaka et al.
INTERNAL MEDICINE (2000)
Share Paper
